Aetna modified CPB 0643 for vaginitis diagnosis, effective December 17, 2025. Here's what billing teams need to know.
Aetna, a CVS Health company, updated Clinical Policy Bulletin 0643 covering the diagnosis of vaginitis. This Aetna vaginitis coverage policy draws clear lines between covered molecular testing — including CPT codes 81513, 81514, 81515, 87661, 87801, and 87905 — and procedures the plan considers experimental or non-covered. If your lab, OB/GYN practice, or women's health group bills these codes for Aetna members, this update is directly relevant to your claim submission process.
Quick-Reference Table
| Field | Detail |
|---|---|
| Payer | Aetna, a CVS Health company |
| Policy | Diagnosis of Vaginitis |
| Policy Code | CPB 0643 |
| Change Type | Modified |
| Effective Date | December 17, 2025 |
| Impact Level | Medium |
| Specialties Affected | OB/GYN, Women's Health, Clinical Laboratory, Primary Care, Infectious Disease |
| Key Action | Audit your vaginitis testing charge capture against the covered indications in CPB 0643 before submitting claims with the new effective date |
Aetna Vaginitis Coverage Criteria and Medical Necessity Requirements 2025
The CPB 0643 Aetna system draws medical necessity around one clear trigger: symptoms of vaginitis or documented risk factors. Testing without that clinical justification in the documentation will not meet coverage criteria.
Aetna considers the following medically necessary for vaginitis diagnosis:
Nucleic acid amplification and direct DNA probe testing for trichomonas, Candida, and Gardnerella — including the Affirm VIP III panel — is covered when a member has dysuria or active symptoms of vaginitis. The relevant CPT codes here are 87480 (Candida, direct probe), 87481 (Candida, amplified probe), 87510 (Gardnerella, direct probe), 87511 (Gardnerella, amplified probe), 87660 (Trichomonas vaginalis, direct probe), and 87661 (Trichomonas vaginalis, amplified probe).
PCR-based bacterial vaginosis panels are covered for symptomatic women. This includes named panels from major labs: BD MAX Vaginal Panel (Becton Dickinson), Aptima BV (Hologic), NuSwab VG (LabCorp), OneSwab BV Panel (Medical Diagnostic Laboratories), and SureSwab BV (Quest Diagnostics). The CPT codes that map to these panels include 81513 (quantitative real-time RNA amplification for BV), 81514 (quantitative real-time DNA amplification for BV and vaginitis), 81515 (real-time PCR for BV and vaginitis), and 0557U (real-time DNA amplification for Atopobium/Gardnerella/Lactobacillus markers).
Candida vaginitis PCR testing — covering albicans, glabrata, krusei, parapsilosis, and tropicalis — is also covered under this Aetna vaginitis coverage policy for symptomatic women. Panels such as GenPath GenPap, INFINITI Candida Vaginosis QUAD Assay, and Quest's SureSwab test fall into this bucket.
Sialidase activity measurement in vaginal fluid — the BVBlue test, billed as CPT 87905 — is covered for women with vaginitis symptoms. This is a simple enzymatic assay, and it is a covered benefit when the symptom criterion is met.
pH and amine testing via CPT 82120 (amines, vaginal fluid, qualitative) and CPT 83986 (pH, body fluid, except blood) — including the FemExam test — is covered for symptomatic women. These lower-tech tests are still viable, covered options.
Trichomonas vaginalis screening with nucleic acid amplification, direct probe, or antigen detection gets coverage even without active symptoms — but only for women with specific risk factors. Those risk factors are: new or multiple sex partners, history of sexually transmitted diseases, exchange of sex for payment, or injection drug use. CPT 87661 (amplified probe) and CPT 87808 (antigen detection by immunoassay) are the primary codes here. The ICD-10-CM codes supporting this risk-factor pathway include injection drug use codes (F11.x, F13.x series) and STD history codes.
The policy does not mention prior authorization requirements explicitly for these tests. That said, high-cost multi-organism panels — especially the newer PLA codes like 0455U and 0557U — often trigger prior auth review in practice. Talk to your Aetna provider relations contact if you're unsure whether prior authorization applies to a specific panel in your state.
Aetna Vaginitis Exclusions and Non-Covered Indications
Aetna is explicit about what it will not pay for under this coverage policy. These are not gray areas — they are flat denials waiting to happen if you bill them for vaginitis.
Pap smear for Candida vulvo-vaginitis diagnosis is not covered. If your provider orders a Pap with the intent of diagnosing Candida infection, the cytopathology codes (CPT 88141–88175) and the Pap smear HCPCS codes (G0123, G0124, G0141–G0148, P3000, P3001, Q0091) will not be covered for this indication. Pap smears have a defined screening purpose — Aetna does not recognize them as a diagnostic tool for fungal vaginitis.
Routine screening for Candida and Gardnerella in asymptomatic women is not covered. The word "asymptomatic" is doing heavy lifting here. Aetna will not reimburse vaginitis pathogen testing in the absence of documented symptoms, regardless of the test's analytical capabilities.
uBiome SmartJane is specifically named as non-covered. Aetna does not list a specific CPT code for this test, but the cytopathology CPT codes (88141–88175) and associated HCPCS codes are listed in the non-covered group because this test has been billed using those codes.
The Bridge Diagnostics vaginal pathogen panel — CPT 0330U, which identifies 27 organisms — is not covered for vaginitis or any other indication. This is a blanket exclusion. If your lab offers this panel, do not bill 0330U to Aetna expecting reimbursement. You will get a claim denial.
The real risk here is over-testing in asymptomatic patients. Broad panel ordering has been trending upward in women's health labs. Aetna is drawing a hard line: symptoms first, then testing.
Coverage Indications at a Glance
| Indication | Status | Relevant CPT Codes | Notes |
|---|---|---|---|
| NAAT/DNA probe for trichomonas, Candida, Gardnerella — symptomatic women | Covered | 87480, 87481, 87510, 87511, 87512, 87660, 87661 | Requires documented dysuria or vaginitis symptoms |
| PCR-based BV panel (BD MAX, Aptima BV, NuSwab VG, OneSwab, SureSwab) — symptomatic women | Covered | 81513, 81514, 81515, 0557U | Symptom documentation required |
| Candida vaginitis PCR (albicans, glabrata, krusei, parapsilosis, tropicalis) — symptomatic women | Covered | 87480, 87481, 87801, 0557U | Covers five Candida species |
| Sialidase activity testing (BVBlue) — symptomatic women | Covered | 87905 | Simple enzymatic assay; symptom criterion applies |
| pH and amine testing (FemExam) — symptomatic women | Covered | 82120, 83986 | Lower-tech but fully covered |
| Trichomonas vaginalis screening — high-risk asymptomatic women | Covered | 87661, 87808, 87660 | Requires documented risk factor: new/multiple partners, STD history, sex for payment, or injection drug use |
| Wet mount smear for infectious agents | Covered | 87210 | Standard of care, covered with symptoms |
| Chlamydia/gonorrhea NAAT — included panels | Covered | 0353U, 0455U, 87491, 87591 | Covered when included in a covered vaginitis panel |
| Pap smear for Candida vulvo-vaginitis diagnosis | Not Covered | 88141–88175, G0123–G0148, P3000, P3001, Q0091 | Pap is not a covered diagnostic tool for fungal vaginitis |
| Routine Candida/Gardnerella screening — asymptomatic women | Not Covered | 87480, 87481, 87510, 87511 | Asymptomatic = no coverage, regardless of test type |
| uBiome SmartJane | Not Covered | No specific code | Listed explicitly as non-covered |
| Bridge Diagnostics 27-organism vaginal pathogen panel | Not Covered | 0330U | Blanket exclusion, all indications |
Aetna Vaginitis Billing Guidelines and Action Items 2025
The effective date of December 17, 2025 is already past. If you haven't reviewed your vaginitis billing workflow yet, do it now.
| # | Action Item |
|---|---|
| 1 | Audit your vaginitis charge capture for symptom documentation. Every covered test under CPB 0643 ties to "symptoms of vaginitis." Pull claims from the last 90 days for CPT codes 81513, 81514, 81515, 87661, 87905, 82120, and 83986. Confirm the corresponding encounter notes document dysuria or active vaginitis symptoms. If they don't, you have a claim denial risk sitting in your accounts receivable. |
| 2 | Flag CPT 0330U (Bridge Diagnostics panel) as non-covered for Aetna. Update your charge master or lab order interface to alert providers ordering this test for Aetna members. A claim denial on 0330U is not a gray area — the policy excludes it for all indications. |
| 3 | Build a risk-factor checklist for Trichomonas screening in asymptomatic patients. Covered Trichomonas screening without symptoms requires documented risk factors: new or multiple partners, STD history, exchange of sex for payment, or injection drug use. Use ICD-10 codes from the F11.x and F13.x series for injection drug use. Without this documentation, CPT 87661 or 87808 will likely deny. |
| 4 | Remove uBiome SmartJane from any Aetna-covered test menu immediately. If your practice or lab still offers this test, Aetna will not pay for it. Patients who receive it expecting insurance coverage will face unexpected out-of-pocket costs — and you'll face a write-off. |
| 5 | Review PLA codes 0353U, 0455U, and 0557U for prior auth exposure. These newer proprietary lab analysis codes are covered when criteria are met, but they carry higher reimbursement and often attract payer scrutiny. If you haven't mapped out Aetna prior authorization requirements for these codes by lab location and plan type, do that before submitting claims. If your billing team isn't sure, loop in your compliance officer or billing consultant before submitting high-dollar panel claims. |
| 6 | Verify that Pap smear orders are not being used to diagnose Candida vaginitis. If your EMR allows a Pap to be ordered with a Candida diagnosis, that combination will fail Aetna's vaginitis billing guidelines. The cytopathology codes (88141–88175) and screening HCPCS codes (G0123–G0148, P3000, P3001, Q0091) are excluded from this policy for this purpose. |
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for Vaginitis Diagnosis Under CPB 0643
Covered CPT Codes (When Selection Criteria Are Met)
| Code | Description |
|---|---|
| 0353U | Infectious agent detection by nucleic acid (DNA), Chlamydia trachomatis and Neisseria gonorrhoeae, multiple types |
| 0455U | Infectious agents (sexually transmitted infection), Chlamydia trachomatis, Neisseria gonorrhoeae, and additional analytes |
| 0557U | Infectious disease (bacterial vaginosis and vaginitis), real-time amplification of DNA markers for Atopobium/Gardnerella/Lactobacillus |
| 81513 | Infectious disease, bacterial vaginosis, quantitative real-time amplification of RNA markers for Atopobium vaginae, Gardnerella vaginalis, and Lactobacillus species |
| 81514 | Infectious disease, bacterial vaginosis and vaginitis, quantitative real-time amplification of DNA markers for Gardnerella vaginalis, Candida species, and Trichomonas vaginalis |
| 81515 | Infectious disease, bacterial vaginosis and vaginitis, real-time PCR amplification of DNA markers for Gardnerella vaginalis and Atopobium vaginae |
| 82120 | Amines, vaginal fluid, qualitative |
| 83986 | pH, body fluid, except blood |
| 87210 | Smear, primary source with interpretation; wet mount for infectious agents |
| 87480 | Infectious agent detection by nucleic acid (DNA or RNA); Candida species, direct probe technique |
| 87481 | Infectious agent detection by nucleic acid (DNA or RNA); Candida species, amplified probe technique |
| 87491 | Infectious agent detection by nucleic acid (DNA or RNA); Chlamydia trachomatis, amplified probe technique |
| 87510 | Infectious agent detection by nucleic acid (DNA or RNA); Gardnerella vaginalis, direct probe technique |
| 87511 | Gardnerella vaginalis, amplified probe technique |
| 87512 | Gardnerella vaginalis, quantification |
| 87591 | Infectious agent detection by nucleic acid (DNA or RNA); Neisseria gonorrhoeae, amplified probe technique |
| 87660 | Infectious agent detection by nucleic acid (DNA or RNA); Trichomonas vaginalis, direct probe technique |
| 87661 | Infectious agent detection by nucleic acid (DNA or RNA); Trichomonas vaginalis, amplified probe technique |
| 87798 | Infectious agent detection by nucleic acid (DNA or RNA), not otherwise specified; amplified probe technique |
| 87799 | Quantification, each organism |
| 87801 | Infectious agent detection by nucleic acid (DNA or RNA), multiple organisms; amplified probe(s) technique |
| 87808 | Infectious agent antigen detection by immunoassay with direct optical observation; Trichomonas vaginalis |
| 87905 | Infectious agent enzymatic activity other than virus (e.g., sialidase activity in vaginal fluid — BVBlue test) |
Not Covered / Experimental Codes
| Code | Type | Description | Reason |
|---|---|---|---|
| 0330U | CPT (PLA) | Infectious agent detection by nucleic acid (DNA or RNA), vaginal pathogen panel, identification of 27 organisms (Bridge Diagnostics) | Not covered for vaginitis or any other indication |
| 88141 | CPT | Cytopathology, cervical or vaginal | Not covered for Candida vaginitis diagnosis; uBiome SmartJane not covered |
| 88142 | CPT | Cytopathology, cervical or vaginal | Not covered for Candida vaginitis diagnosis |
| 88143 | CPT | Cytopathology, cervical or vaginal | Not covered for Candida vaginitis diagnosis |
| 88144 | CPT | Cytopathology, cervical or vaginal | Not covered for Candida vaginitis diagnosis |
| 88145 | CPT | Cytopathology, cervical or vaginal | Not covered for Candida vaginitis diagnosis |
| 88146 | CPT | Cytopathology, cervical or vaginal | Not covered for Candida vaginitis diagnosis |
| 88147 | CPT | Cytopathology, cervical or vaginal | Not covered for Candida vaginitis diagnosis |
| 88148 | CPT | Cytopathology, cervical or vaginal | Not covered for Candida vaginitis diagnosis |
| 88149 | CPT | Cytopathology, cervical or vaginal | Not covered for Candida vaginitis diagnosis |
| 88150 | CPT | Cytopathology, cervical or vaginal | Not covered for Candida vaginitis diagnosis |
| 88151 | CPT | Cytopathology, cervical or vaginal | Not covered for Candida vaginitis diagnosis |
| 88152 | CPT | Cytopathology, cervical or vaginal | Not covered for Candida vaginitis diagnosis |
| 88153 | CPT | Cytopathology, cervical or vaginal | Not covered for Candida vaginitis diagnosis |
| 88154 | CPT | Cytopathology, cervical or vaginal | Not covered for Candida vaginitis diagnosis |
| 88155 | CPT | Cytopathology, cervical or vaginal | Not covered for Candida vaginitis diagnosis |
| 88164 | CPT | Cytopathology, slides, cervical or vaginal | Not covered for Candida vaginitis diagnosis |
| 88165 | CPT | Cytopathology, slides, cervical or vaginal | Not covered for Candida vaginitis diagnosis |
| 88166 | CPT | Cytopathology, slides, cervical or vaginal | Not covered for Candida vaginitis diagnosis |
| 88167 | CPT | Cytopathology, slides, cervical or vaginal | Not covered for Candida vaginitis diagnosis |
| 88174 | CPT | Cytopathology, cervical or vaginal | Not covered for Candida vaginitis diagnosis |
| 88175 | CPT | Cytopathology, cervical or vaginal | Not covered for Candida vaginitis diagnosis |
| G0123 | HCPCS | Screening cytopathology, cervical or vaginal | Not covered for vaginitis indications listed in CPB |
| G0124 | HCPCS | Screening cytopathology, cervical or vaginal | Not covered for vaginitis indications listed in CPB |
| G0141 | HCPCS | Screening cytopathology smears, cervical or vaginal | Not covered for vaginitis indications listed in CPB |
| G0142 | HCPCS | Screening cytopathology smears, cervical or vaginal | Not covered for vaginitis indications listed in CPB |
| G0143 | HCPCS | Screening cytopathology smears, cervical or vaginal | Not covered for vaginitis indications listed in CPB |
| G0144 | HCPCS | Screening cytopathology smears, cervical or vaginal | Not covered for vaginitis indications listed in CPB |
| G0145 | HCPCS | Screening cytopathology smears, cervical or vaginal | Not covered for vaginitis indications listed in CPB |
| G0146 | HCPCS | Screening cytopathology smears, cervical or vaginal | Not covered for vaginitis indications listed in CPB |
| G0147 | HCPCS | Screening cytopathology smears, cervical or vaginal | Not covered for vaginitis indications listed in CPB |
| G0148 | HCPCS | Screening cytopathology smears, cervical or vaginal | Not covered for vaginitis indications listed in CPB |
| P3000 | HCPCS | Screening Papanicolaou smear, cervical or vaginal | Not covered for vaginitis indications listed in CPB |
| P3001 | HCPCS | Screening Papanicolaou smear, cervical or vaginal | Not covered for vaginitis indications listed in CPB |
| Q0091 | HCPCS | Screening Papanicolaou smear, obtaining, preparing and conveyance of cervical or vaginal smear to lab | Not covered for vaginitis indications listed in CPB |
Key ICD-10-CM Diagnosis Codes
| Code | Description |
|---|---|
| A59.01 | Trichomonal vulvovaginitis |
| B37.31 | Candidiasis of vulva and vagina |
| B37.32 | Candidiasis of vulva and vagina |
| B96.89 | Other specified bacterial agents as the cause of diseases classified elsewhere (Gardnerella vaginitis) |
| F11.10–F11.19 | Opioid abuse (injection drug use — supports Trichomonas screening coverage) |
| F11.20–F11.229 | Opioid dependence (injection drug use — supports Trichomonas screening coverage) |
| F13.10–F13.19 | Sedative/hypnotic abuse (injection drug use — supports Trichomonas screening coverage) |
Note: The full ICD-10-CM code list under CPB 0643 includes 323 codes. The codes above represent the primary clinical categories. Pull the full list from the source policy at app.payerpolicy.org/p/aetna/0643 to build your complete crosswalk.
Get the Full Picture for CPT 87905
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.